![]() | Only 14 pages are availabe for public view |
Abstract The synthetic prostaglandin, misoprostol (PGE1 analogue), has largely replaced all other techniques for pregnancy termination particularly in the second trimester because of its efficacy, safety, cost, easy to use and easy to store properties. There were series reported a higher incidence of uterine rupture and major hemorrhage in women with prior caesarean scar as compared to women with unscarred uteri following various techniques of mid-trimester pregnancy termination. The safety profile of misoprostol as abortifacient or labour-inducing agent (after 20 completed weeks of gestation) in women with a Caesarean scar is yet to be established. Although case reports of uterine rupture have been published with both scarred and unscarred uteri, several other studies have shown misoprostol to be a safe agent for use in post-Caesarean pregnancies. |